US Patent Issued to VANDERBILT UNIVERSITY on May 12 for "HIV/HCV cross-reactive antibodies and uses thereof" (Tennessee Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,091, issued on May 12, was assigned to VANDERBILT UNIVERSITY (Nashville, Tenn.).

"HIV/HCV cross-reactive antibodies and uses thereof" was invented by Kelsey Pilewski (Nashville, Tenn.) and Ivelin Stefanov Georgiev (Brentwood, Tenn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to antibodies and uses thereof for treating an HIV infection, an HCV infection, or an HIV/HCV co-infection."

The patent was filed on April 3, 2020, under Application No. 17/600,893.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FP...